Insider Cluster (2 insiders) ·Filed May 22, 2026

RPRX

Royalty Pharma plc
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $883K total
Actionable Insight • Neutral

The dollar amount is too small to signal any material change in business outlook. Monitor upcoming quarterly earnings for any fundamental shifts; these sales are routine and non-actionable.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
RPRX ▲ +9.52% at T+60d
NEUTRAL call ✓ call won +9.52% · α vs SPY +6.33% · entry $54.50 → $59.69
Entry anchored
May 21, 2026
via day open
T+1d
-1.17%
call -1.17% · α -1.76%
$53.86
settled 4mo ago
T+5d
+1.25%
call +1.25% · α -0.41%
$55.18
settled 4mo ago
T+20d
-1.83%
call -1.83% · α -0.42%
$53.50
settled 3mo ago
T+60d
+9.52%
call +9.52% · α +6.33%
$59.69
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Two insiders at Royalty Pharma sold a combined $883K in open-market transactions over a one-week window. The sales represent ~0.003% of the $30.6B market cap, a trivial amount that is routine and non-informative. No material business catalyst is evident from the filing.

Key Financial Metrics

Direction
selling
Total Value
$883.0K
Insiders
2

Key Facts

  • Director Norden Gregory sold 3,000 shares at ~$53.00 for $161K on 2026-05-14.
  • EVP Marshall Urist sold 13,684 shares at ~$52.75 for $722K on 2026-05-20.
  • Total insider sales of $883K represent ~0.003% of RPRX's $30.6B market cap.
  • No insider purchases were reported in the cluster window.
  • Recent 30-day insider activity includes 4 prior sales totaling $3.2M, consistent with routine liquidity-driven selling.

Financial Impact

Total insider sales of $883K, or ~0.003% of market cap — economically negligible.

insider holdings

Risk Factors

  • Insider sales could increase if the stock continues to appreciate, but no bearish signal is present here.
  • No identifiable catalyst from this filing alone.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (16 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-RPRX-1779412846308
18 reports for RPRX
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +15.20%May 6, 2026
Filters
Rows
Reports for RPRX — sortable, filterable
TypeNow
Sep 4, 2026
27d ago
Press Release
BEARISH ★ 5/10
$60.59 $58.47▲ +3.50%▲ +2.38%$57.16 (+5.66%)
Aug 19, 2026
6w ago
Insider Cluster
NEUTRAL ★ 3/10
$61.73 $61.80▲ +0.11%▲ +0.50%$57.16 (−7.40%)
Aug 12, 2026
7w ago
144
NEUTRAL ★ 3/10
$58.56 $60.58▲ +3.45%▲ +5.41%$57.16 (−2.39%)
Aug 5, 2026
8w ago
8-K
BULLISH ★ 6/10
$57.75 $59.22▲ +2.55%▲ +2.19%$57.16 (−1.02%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$57.77 $57.96▲ +0.33%▼ −0.60%$57.16 (−1.06%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$57.77 $57.96▲ +0.33%▼ −0.60%$57.16 (−1.06%)
May 28, 2026
18w ago
Insider Cluster
NEUTRAL ★ 4/10
$55.76 $55.87▲ +0.20%▲ +2.72%$57.16 (+2.51%)
May 28, 2026
18w ago
8-K
NEUTRAL ★ 4/10
$55.76 $54.97▼ −1.42%▼ −1.12%$57.16 (+2.51%)
May 22, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$54.50 $55.18▲ +1.25%▼ −0.41%$57.16 (+4.88%)
May 15, 2026
19w ago
Insider Cluster
NEUTRAL ★ 3/10
$52.07 $53.86▲ +3.44%▲ +1.82%$57.16 (+9.78%)
Showing 10 of 18

US Market Status

Market Closed — Opens Mon (65h 2m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 22, 2026